China and Denmark launch a new round of cooperation in new drug research and development

National Centre for New Drug Screening announced that it will recently sign a framework agreement with the Danish Centre for Biotechnology Research and Innovation and the Faculty of Pharmacy of the University of Copenhagen to build a strong team of comprehensive innovation capabilities for cooperative research on drug discovery and development, taking advantage of the complementary professional strengths of the three parties in the fields of life sciences and pharmaceutical technologyThe Danish Centre for Biotechnology Research and Innovation will identify new targets for drug action on the basis of clarifying the mechanisms for the development of importantdiseasesChina's National New Drug Screening Center will exert its strong strength in the field of compound bioactivity screening, providing a "source" for subsequent researchThe Faculty of Pharmacy of the University of Copenhagen will use its extensive practical experience in drug chemistry to optimize and identify drug-led compounds to reveal their physical and chemical propertiesDr Kristian Helin, Director of the Danish Centre for Biotechnology Research and Innovation, said the collaboration with The National Center for New Drug Screening and the School of Pharmacy at the University of Copenhagen will strengthen our ability to develop new drugs to fight cancer and treat other common diseasesOn January 29, Professor Ding Jian, Director of the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences, and other members of the delegation from the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences attended the signing ceremony in Copenhagen(reproduced from the Journal of Medicine and Economics)